在人类NRAS基因中识别和分析致癌性非同义单核酸多态:一个独家的in silico研究
Md Mozibullah1, Hadieh Eslampanah Seyedi2, Marina Khatun1
1Department of Biochemistry and Molecular Biology, Mawlana Bhashani Science and Technology University, Santosh, Tangail 1902, Bangladesh.
Journal, genetic engineering & biotechnology
|May 26, 2024
概括
这项研究使用计算工具确定了破坏性和促进癌症的NRAS基因变异. 这些发现有助于了解NRAS相关的癌症,并制定个性化医疗策略.
科学领域:
- 遗传学和分子生物学
- 生物信息学是一种生物信息学.
- 癌症研究 癌症研究
背景情况:
- 该NRAS基因编码N-ras蛋白,对于细胞信号,增殖和生存至关重要.
- 在NRAS中的非同义单核酸多态 (nsSNP) 可以改变蛋白质结构和功能,可能导致癌症等疾病.
- 缺乏对NRAS nsSNP进行全面的分析,以识别有害和致癌变异.
研究的目的:
- 为了对人类NRAS基因进行in silico分析.
- 识别与癌症相关的潜在有害和瘤性NSSNP.
- 为未来的实验研究和个性化医学提供基础.
主要方法:
- 利用 10 种不同的计算工具分析了 140 种 NRAS 基因的误解变异.
- 识别的nsSNP根据算法分析预测是有害的.
- 根据它们在保护区域的位置来过有害变体,以识别致癌变体.
主要成果:
- 确定了7个nsSNP (I55R,G60E,G60R,Y64D,L79F,D119G,V152F) 作为具有破坏性的.
- 进一步确定G60E,G60R和D119G是致癌变体,因为它们位于保护区.
- G60E和G60R变种显示与肺,骨髓瘤和前列腺腺癌有关.
结论:
- 在人类NRAS基因中通过in silico方法成功识别了有害和致癌的误解变异.
- 鉴定的变异可以指导未来的实验研究.
- 这些发现有助于开发针对NRAS相关癌症的个性化医疗方法.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.7K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.1K
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
